Heart failure drug shows promise in reducing heart attacks and strokes
NCT ID NCT07341893
First seen Jan 17, 2026 · Last updated May 17, 2026 · Updated 17 times
Summary
This study tested the drug sacubitril-valsartan in 60 adults with heart failure and reduced pumping ability. The goal was to see if the drug could lower the risk of major heart problems like heart attack, stroke, or death, and improve the heart's pumping strength. Participants had moderate to severe heart failure and took the medication as part of their regular care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Damanhur Medical National Institute
Damanhūr, Elbehairah, 31527, Egypt
Conditions
Explore the condition pages connected to this study.